[1]
R. S. Paul, D. K. Roy, and H. S. Chowdhury, “Febuxostat and Renal Outcomes in Stage 3-4 CKD Patients with Asymptomatic Hyperuricemia: A Prospective Observational Study”, J Rang Med Col., vol. 11, no. 1, pp. 3–8, May 2026.